Flying a thrust-vectoring rocket can be a challenge, and even more so if you stack multiple stages and a minimalist flight computer on top of it all. But [Joe Barnard] is not one to shy away from ...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $10.12 and last traded at $10.21, with a volume of 1907894 shares. The stock ...

Rocket Pharmaceuticals ... Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based ...